Skip to main content
. 2015 Sep 11;6(31):32027–32038. doi: 10.18632/oncotarget.5184

Table 2. Fourteen HER2-positive and one HER2-negative with HER2 mutation patients.

Sample.ID ERBB2 ERBB2 Mutation Amplification value GRB2 mRNA HER2–3 pathway
OS191 Amp. (14.53) No 14.53 0.674 0.447
OS226 p.P420fs (0.22) Amp. (13.99) Yes 13.99 0.144 −0.591
OS230 Amp. (22.38) No 22.38 0.897 0.178
OS240 S413L (0.01) Amp. (16.39) Yes 16.39 0.431 −0.136
OS244 Amp. (12.36) No 12.36 0.286 −0.037
OS245 Amp. (16.04) No 16.04 N/A N/A
OS256 S72A (0.01) Amp. (25.93) Yes 25.93 N/A N/A
OS257 Amp. (30.13) No 30.13 1.716 −0.470
OS265 Amp. (14.09) No 14.09 1.189 −0.156
OS306 Amp. (13.8) No 13.8 N/A N/A
OS251 P562S (0) Amp. (20) yes 20 −0.024 −0.593
OS314 Amp. (9.52) No 9.52 1.388 −0.485
OS321 Q692X (0.02) Amp. (5.39) Yes 5.39 0.541 −0.206
OS337 Amp. (3.99) No 3.99 0.301 0.040
OS266 L755S (0.19) None Yes 2 0.144 −0.591

*NA: not available